Vitamin D and cancer
- 1 May 2002
- journal article
- review article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 13 (5) , 252-264
- https://doi.org/10.1016/s0955-2863(02)00183-3
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Prevention of N-Methyl-N-Nitrosourea-Induced Mammary Carcinogenesis in Rats by 1alpha-Hydroxyvitamin D5JNCI Journal of the National Cancer Institute, 2000
- Induction of differentiation by 1α-hydroxyvitamin D5 in T47D human breast cancer cells and its interaction with vitamin D receptorsEuropean Journal Of Cancer, 2000
- Prevention of Preneoplastic Mammary Lesion Development by a Novel Vitamin D Analogue, 1 -Hydroxyvitamin D5JNCI Journal of the National Cancer Institute, 1997
- Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.Journal of Clinical Investigation, 1997
- Ligand-dependent Cross-talk between Steroid and Thyroid Hormone ReceptorsPublished by Elsevier ,1996
- Safety and efficacy of oral calcitriol (1, 25 -dihydroxyvitamin D3) for the treatment of psoriasisBritish Journal of Dermatology, 1996
- Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3 ) for the treatment of psoriasisBritish Journal of Dermatology, 1996
- Inhibition of intestinal tumor development in rat multi-organ carcinogenesis and aberrant crypt foci in rat colon carcinogenesis by 22-oxa-calcitriol, a synthetic analogue of 1α,25-dihydroxyvitamin D3Carcinogenesis: Integrative Cancer Research, 1995
- Phosphorylation is involved in transcriptional activation by the 1,25-dihydroxyvitamin D3 receptorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Effect of vitamin D2 and vitamin D3 on the serum concentrations of 1,25(OH)2D2, and 1,25(OH)2D3 in normal subjectsActa Endocrinologica, 1987